chrisvoncsefalvay/vaers-outcomes huggingface dataset:
LIGHT FATIGUE; This spontaneous report received from a patient concerned a 64 year old of unspecified sex. The patient's weight was 188 pounds, and height was 69 inches. The patient's past medical history included: covid-19, and concurrent conditions included: alcohol use, non-smoker, and plant allergy, and other pre-existing medical conditions included: No drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042821A, expiry: UNKNOWN) dose was not reported, administered on 04-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-AUG-2021, the patient experienced light fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from light fatigue on 06-AUG-2021. This report was non-serious. This case, from the same reporter is linked to 20210815214.
Aches and pain in left arm, has little strength in arm, can't raise arm over head, no redness or swelling at injection site, symptoms are improving but not completely resolved.
I was at a summer school and the guy sitting behind me had COVID-19. The next day I had a sore throat so I tested myself and was positive for COVID-19. I became dehydrated the next day and went to the emergency room where they prescribed PAXLOVID. My symptoms immediately began to improve and at this point I feel completely recovered.
Severe pain in my right ankle, swelling and limping, continuing to get worse until I had surgery on July 8, 2021
Dx transverse meylitis 12/7/02. Sudden onset. Etiology not known. Received two flu vaccines 10/08/2002, 11/07/2002. 60 day follow up states pt has not recovered. Transverse myelitis- no change in symptoms. The annual follow up received on 1/13/04 states persistent paralysis. Discharge summary states deep vein thrombosis. msv Medical records state anemia, urinary retention, urinary infection. msv
Severe fatigue  and slight nausea  start 12 hrs after sshot  ending28 hours later.
BlurredVision, Myalgia, Arthralgia, Fever, NauseaVomiting, chills, fatigue,  Narrative:
Approximately 24 hours after receiving the vaccine, I began having joint pain in my hands b/l. After the second vaccine, it worsened, and I began having joint pain in the hips, knees, feet, hands, and back. The pain is worse in humid weather, or if it is about to rain. Pain is made better with Tylenol Arthritis.
This spontaneous report as received from a field representative via nurse practitioner refers to a 21 year old female patient. There were no pertinent medical history or drug allergies/reactions. The patient has no history of seizures, but that her sister did have a history of seizures. On 29-AUG-2014, the patient was vaccinated with GARDASIL, injection, (dose, lot # and expired date were not reported) intramuscular in the office. There was no concomitant medication. Within a short amount of time after administration (on an unknown date in 2014) the patient experienced some kind of seizure activity (the specific activity was unspecified). On an unknown date in 2014, the patient recovered and walked out of the office on her own however the Nurse Practitioner suggested the patient seek medical attention at the local Emergency Room, but it was unspecified if the patient did so. The treatment for adverse event was not given while in the office, and was unspecified outside of the office. Lab diagnostics studies were not performed while in the office, and were unspecified outside of the office. The relationship between adverse event and GARDASIL was not reported. Upon internal interview, adverse event was considered to be medically significant. Additional information has been requested.
he has elevated body temperature, continued fever every day that does not seem to go away/It is not a high fever, it is around 100 F at the most.; swollen glands on injection site; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (he has elevated body temperature, continued fever every day that does not seem to go away/It is not a high fever, it is around 100 F at the most.) and VACCINATION SITE LYMPHADENOPATHY (swollen glands on injection site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058C21A and 050C21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included METOPROLOL TARTRATE for Blood pressure.   On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (he has elevated body temperature, continued fever every day that does not seem to go away/It is not a high fever, it is around 100 F at the most.) and VACCINATION SITE LYMPHADENOPATHY (swollen glands on injection site). At the time of the report, PYREXIA (he has elevated body temperature, continued fever every day that does not seem to go away/It is not a high fever, it is around 100 F at the most.) and VACCINATION SITE LYMPHADENOPATHY (swollen glands on injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) around 100 F.         No treatment information was provided.   This case was linked to MOD-2021-325338 (Patient Link).
My due date is 05/07/2023, so at the time of my vaccination I was about 2 weeks pregnant. I got my influenza vaccine about two days after receiving my COVID-19 booster. They prescribed me low-dose of aspirin for preeclampsia and mesalamine for ulcerative colitis. On 12/21/2022, I started feeling pretty congested and stuffed up but thought it was because of temperatures dropping and possible sinus infection. On 12/23/2022, my congestion was getting progressively worse which became a heavy cough after. On Christmas Day, I went to the hospital because I knew it wasn't a normal pregnancy sinus infection. They tested me for COVID-19, influenza, and RSV for any viral infections; only the COVID-19 test came back positive. They prescribed me an antibiotics azithromycin to help fight potential bronchitis or some bacterial infection my body could be fighting in addition to COVID-19. Right now, I still have some congestion which is causing coughing and phlegm removal from my system. I never developed a fever, my sore throat is gone, and I haven't had a headache since Christmas.
Patient state that his right arm started to get really sore around 8pm on 1/25/18 that he can't even move the arm. He had taken off work the next day because he can't even move his arm. He stopped by the pharmacy around 2pm to report the adverse events. on 1/27/18, I called him back to ask how he's doing. He said he's still sore but he can at least move his arm now.
2 x 2 cm area of induration, swelling, mild tenderness at routine site left deltoid area.  Patient seen 12/1.  Recommended Tylenol or Moltrin, ice pack, Benadryl.
Period has been erratic and growing longer. The first month, I had two periods within 28 days. Since then, my period has only gotten longer, culminating in a period lasting over 2 weeks. My current birth control that managed my cycle previously is not working.
4 Feb 16 - (L) upper arm with raised pustule vanished by 9-20 cm red, warm, inflamed skin with streaking down arm and under arm. Significant (L) axillary lymph node enlargement.
Breakthrough case admission after 2 vaccines' Pfizer 2/25/21 Lot# En6200;  Pfizer 3/18/21 Lot# EN6208
Patient had been having weakness and fatigue for 3 days. Presented to the hospital on 10/7/22 after almost having a fall. He claims to have tested positive for COVID at home a week prior. Tested positive in the emergency dept on 10/7/22. He was discharged home from the ED on 10/7 but returned on 10/8 after having another fall.
Starting 1/27/21 ringing in left ear noted. 1/28/21 headache and left ear pain begins.  1/29/21 Started on Cefdinir for Left otitis Media.  Ear pain continued and began to worsen over a week with headache pain in left temple and all the way down through neck. Pain was throbbing and Ibuprofen/Tylenol had to be taken around the clock.  On 2/6/21 began Prednisone pack for possible nerve pain.  Pain has eased over the past 5 days.  Continues now left ear and left neck, however very mild.
Child c/o itching at injection site. Mom states child was broke out into hives all over body. Injection site was swollen and had heat. Mom gave BENADRYL and hives cleared with 45 minutes. Whelp remains at injection site. Instructed to continue BENADRYL and go to ER if worsens. Reaction occurred to (L) back of arm where varicella injection given.
Pt called 11/13/17 and explained that her arm is red and has a white spot at the injection site. No pain, itchiness, or pus. I looked at it, and it is lightly red, around 2 inch in diameter. She got the vaccine on 11/12/17 in the afternoon.
Hives on trunk, thighs, and arms. They were very sore and itchy. Took two 25mg benadryl and the hives cleared up in 2-3 hours.
SWOLLEN LIPS PROGRESSING TO RASH AND ITCHY THROAT.  NO SOB.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's pertinent medical history and current conditions were not reported. On unspecified date in 2010, the patient was vaccinated with first dose of GARDASIL (Lot#, expiry date, route, dose and strength were not reported). On 23-FEB-2016, the patient received second dose in the series which was GARDASIL 9, Lot# L028083, expiry date: 03-SEP-2017 (route, dose and strength were not reported). No adverse effects were reported. No PQC involved. Outcome of the medication error was not reported. Additional information has been requested.
Breaking out on face started Wednesday night; little bumps. Hives on arms, noticed Thursday. Today, Friday, has scattered hives on arms and legs. Doctor advised Benadryl. To see doctor if continued worsening.
Information has been received from a nurse practitioner (NP) concerning a 19 year old female, with no prior medical conditions, who was vaccinated at a hospital facility, by another provider, with a third dose of MMR II. It was noted the patient had not seroconverted for the mumpsvax component of the vaccine, and therefore a third dose was given. On 08 APR 2008 the patient was seen by the NP for lymphadenitis on her right side. Her temperature was 98 degrees. Given that treatment with a course of AUGMENTIN, 1000 mg BID was just started the day of reporting, 08 APR 2008, it was noted that there was no improvement as yet. It was noted that the patient had not gone to the emergency room. Additional information has been requested.
Dizzy; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) and HEADACHE (Headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included Sinus infection (feeling dizzy and had headache).    On 26-Mar-2021 at 4:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced DIZZINESS (Dizzy) and HEADACHE (Headache). At the time of the report, DIZZINESS (Dizzy) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Patient is a 73 y.o. male patient of DO with history of atypical flutter S/P ablation 2020, HTN, IDDM, peripheral neuropathy, chronic back pain, morbid obesity, OSA unable to tolerate CPAP presented to Hospital with hypoxia related to covid19 (3/30) who required 2 liters NC on admission (baseline oxygen none).  Started on Decadron, remdesivir, slowly weaned off of oxygen, developed hyperglycemia secondary to Decadron, today he is feeling much better on room air, back to baseline.  Feels comfortable going home   Acute hypoxemic respiratory failure Covid-19 Virus Infection Date of onset of symptoms: 3/30 Symptoms present on admission: sob Date of covid positive test: 3/31 Vaccination status: vaccinated Imaging: CTPA (3/31) no PE. Ground-glass right lower lobe nodule adjacent to the fissure measuring up to 9 mm mildly increased in size compared to 06/22/2022.  Baseline oxygen PTA: RA Oxygen requirements on admission: 2 liters NC Current oxygen requirements: Saturating well on room air Medical therapy: remdesivir and steroids while in the hospital Consultants following: none on admission Anticipated special isolation end date: 4/9     Hx atypical atrial flutter S/P ablation 2020 Essential HTN Toprol 25 mg daily, Lisinopril 40 mg daily, doxazosin daily Patient advised to check BP twice a day. Same place, same machine, same time. Maintain log and follow up with primary care physician in 1 week. Call primary care physician office if SBP consistently >180 or <90    HLD Resuming atorvastatin 40 mg daily IDDM Type2 A1c: 6.7 (2/28/23)-- on Humalog 15 units prandial, Levemir 18 units BID Check blood sugars ac & HS Currently on: Humalog (conservative) SSI, Humalog (Prandial): 10 units with meals, and Lantus 18 units BID ordered Blood sugar elevated in the hospital while on Decadron As per patient is blood sugar runs 130?180 at home on his home regimen Patient advised to check blood sugar three times a day before meals. Maintain log and follow up with primary care physician in 1 week to adjust dose of insulin accordingly. Call primary care physician office if blood sugar consistently >300 or <60    Chronic back pain Anxiety/depression Insomnia Resuming BuSpar 15 mg TID, Trazodone 100 mg HS PRN, Duloxetine 60 mg, Tizanidine 4 mg, venlafaxine, Hydroxyzine 25 mg TID PRN
Extreme Headache & Fatigue, nausea, chills, body aches, vomiting, diarrhea for 24 hours *Still have on going headaches almost everyday but not as extreme *Still experiencing Extreme Fatigue everyday *Still experiencing Loss of Taste & Smell since COVID positive in January
no adverse event; Medical assistant reported a temperature excursion which was administered to the patient; This spontaneous report was received from a medical assistant concerning, a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications and previous drug reactions or allergies.     On 01-APR-2021 the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA), 1 dosage form (lot number T013546 which was verified to be a valid lot number, expiration date reported and upon internal validation established as 28-OCT-2021), as prophylaxis (frequency, route of administration, anatomical location and vaccination scheme were not reported) (product storage error). The administered vaccine experienced a temperature excursion above 9 degree Celsius (°C) (9.3C) during a time frame of 0 hours 46 minutes and 0 seconds, as recorded by data logger. There was no previous temperature excursion. No adverse events were reported.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.  devicelotnumber: T013546; expirationdate: 28-OCT-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2104USA001375: US-009507513-2104USA001385: US-009507513-2104USA001384: US-009507513-2104USA001383: US-009507513-2104USA001386:
Patient had local reaction at site of injection the size of a tennis ball that was warm, very tender, and patient was tired. All was resolved within 24 hours using ice 4 times daily - RPh followed up with patient day after treatment with ice.
(R) upper arm erythematous, swollen & tender to palpation. (L) deltoid swollen to a lesser extent, mildly warm to touch. AUGMENTIN 875 mg for presumed cellulitis (BID x 10 days).
suspected vaccination failure; Mild case of shingles; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the Shingrix shot(s) and developed a mild case of shingles.  This case was considered as suspected vaccination failure since the details regarding dose number, time to onset and laboratory confirmation was not provided. The case was linked with the cases US2020153380 and US2020153376 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020153376:same reporter US-GLAXOSMITHKLINE-US2020153380:same reporter
Patient reported developing extreme chills and fever within 24 hours of vaccination and had to be taken to ER where she was examined and released.  Patient reported feeling like she had the flu for 3 days and was weak resulting in a fall on day 4.  She has recovered but still feels weak.
Narrative: Pt reported to his clinic to his covid  vaccine dose #2 of dizziness and nausea.
Diffuse papules with central white (small) vesicle on thorax and abdomen with no scabbing.
received second dose 34 days after first dose; unable to move neck; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose 34 days after first dose), MUSCULOSKELETAL STIFFNESS (unable to move neck), CHILLS (chills) and PYREXIA (fever) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose 34 days after first dose), MUSCULOSKELETAL STIFFNESS (unable to move neck), CHILLS (chills) and PYREXIA (fever). On 01-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose 34 days after first dose) had resolved. On 03-May-2021, MUSCULOSKELETAL STIFFNESS (unable to move neck) had resolved. At the time of the report, CHILLS (chills) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant and treatment medications reported.
I have had my period every single day since my vaccine (about 4-5 weeks). This is not normal for me. I have been on a birth control pill that has helped regulate my period and menstrual  cycle. My pills and my cycles have been very regulated for over 2+ years. I very rarely get my period, and when I do, it is very light spotting. However, since getting the vaccine, I have had my period since the vaccine. The flow varies from light to heavy and I continue to have normal period symptoms such as headaches, knee pain and cramps have been present since the vaccine. I have not been under any "stress" and nothing else seems to be out of ordinary for me. I went in for the vaccine while on my period (it was a light/spotting and normal period), thinking it would stop after a few days, but it never stopped.
Very early menstruation for 2 (all) cycles following vaccination.  Ex: normal cycle is 28 days.  Now cycle is 19-20 days.
This spontaneous report was received from a pharmacist via a company representative referring to a female patient of unknown age. The patient's medical history and drug reactions and allergies were not provided. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 for prophylaxis (dose, route, lot# and expiry date were not reported). No concomitant medications were reported. On 06-OCT-2017, the patient developed "redness and inflammation down to her wrist" on an unspecified arm. No treatment was given. The outcome for the aforementioned events was unknown. The causality assessment between PNEUMOVAX 23 and the reported events was unknown.
22OCT94 AM noticed couldn't use mouth very well, couldn't wrinkle nose or wink eye (all on rt side of face); seen by MD 23OCT dx Bell's Palsy; 26OCT94 seen by MD- tx Pred; MD also noticed herpes-like lesion in outer ear canal rt side
I have PCOS and only get my period every few months (approx 2-3 times a year). When it does finally come I have no bloating or breast pain, but I do get occasional cramping and very very heavy bleeding with many blood clots. My first period since the second dose has been incredibly light and the complete opposite of what it normally is. Brest pain, bloating and very light flow. No clots, no heavy flow, no cramping. I've heard lots of other girls talk about how they've had terrible periods after their second dose when they usually have normal ones so I figured I should report that I've had the opposite effect.
PT presented to ED with c/o nausea, vomiting, HA, chills and diarrhea
Took first shot may 8th supposed got second June 8th pharmacy moved second shot to June 17th/ It will be 40 days between first and second shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Took first shot may 8th supposed got second June 8th pharmacy moved second shot to June 17th/ It will be 40 days between first and second shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Took first shot may 8th supposed got second June 8th pharmacy moved second shot to June 17th/ It will be 40 days between first and second shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Took first shot may 8th supposed got second June 8th pharmacy moved second shot to June 17th/ It will be 40 days between first and second shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.